Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01299766 · ClinicalTrials.gov registry record · Phase 3
Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment
A Phase 3 study, sponsored by Thomas Jefferson University.
- Completed
- Registry status
- Phase 3
- Development phase
- 221
- Enrollment target
NCT01299766 is a Phase 3 study that has completed, run by Thomas Jefferson University. The registered enrollment target is 221 participants.
The verdict
NCT01299766, a Phase 3 study, has completed, sponsored by Thomas Jefferson University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 221 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether increasing participation in cognitive, physical, and/or social activities prevents cognitive decline in older African Americans (AAs) with Mild Cognitive Impairment (MCI). Patients with MCI are at increased risk for Alzheimer's Disease (AD); we propose that increasing participation in activities will prevent cognitive decline and may delay the onset of Alzheimer's Disease (AD). We will test this hypothesis by conducting a clinical trial in which older AAs with MCI (aged 65 years and older) will be randomized to Behavior Activation (BA) (a behavioral intervention that increases participation in daily activities) or Supportive Therapy (ST) (a person-centered psychotherapy that involves active listening and offering support focusing on participants' problems and concerns). We hypothesize that BA-treated subjects will have fewer declines in cognitive and functional abilities, fewer depressive and neuropsychiatric symptoms, and better quality of life than ST-treated subjects at 24 months.
Interventions
- BEHAVIORAL Supportive Therapy (ST)
- BEHAVIORAL Behavioral Activation (BA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 221 participants |
| Start Date | 2011-06-21 |
| Est. Completion | 2016-12-13 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01299766
The ClinicalTrials.gov registry entry for NCT01299766 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 221 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Supportive Therapy (ST) is the first listed.
NCT01299766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01299766 about?
NCT01299766 is a clinical study titled "Preventing Cognitive Decline in African Americans With Mild Cognitive Impairment". The goal of this study is to determine whether increasing participation in cognitive, physical, and/or social activities prevents cognitive decline in older African Americans (AAs) with Mild Cognitive Impairment (MCI). Patients with MCI are at increased risk for Alzheimer's Disease (AD); we propose ...
What is the current status of trial NCT01299766?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 221 participants. The study started on 2011-06-21. Estimated completion is 2016-12-13.
What interventions are being tested in trial NCT01299766?
The interventions under investigation include: Supportive Therapy (ST) (BEHAVIORAL), Behavioral Activation (BA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01299766?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.